Ascendis Pharma A (ASND) Total Debt (2021 - 2024)
Historic Total Debt for Ascendis Pharma A (ASND) over the last 5 years, with Q3 2025 value amounting to $771.6 million.
- Ascendis Pharma A's Total Debt rose 1899.74% to $771.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $771.6 million, marking a year-over-year increase of 1899.74%. This contributed to the annual value of $659.0 million for FY2024, which is 1128.41% up from last year.
- According to the latest figures from Q3 2025, Ascendis Pharma A's Total Debt is $771.6 million, which was up 1899.74% from $684.4 million recorded in Q2 2025.
- Ascendis Pharma A's 5-year Total Debt high stood at $771.6 million for Q3 2025, and its period low was $120.1 million during Q4 2021.
- Over the past 5 years, Ascendis Pharma A's median Total Debt value was $649.5 million (recorded in 2024), while the average stood at $621.3 million.
- In the last 5 years, Ascendis Pharma A's Total Debt surged by 36351.31% in 2022 and then tumbled by 734.3% in 2024.
- Ascendis Pharma A's Total Debt (Quarter) stood at $120.1 million in 2021, then skyrocketed by 363.51% to $556.6 million in 2022, then grew by 6.4% to $592.2 million in 2023, then rose by 9.87% to $650.6 million in 2024, then increased by 18.59% to $771.6 million in 2025.
- Its Total Debt stands at $771.6 million for Q3 2025, versus $684.4 million for Q2 2025 and $656.5 million for Q1 2025.